US Pharma MarketingMedical device distribution giant Medline has been slammed for a second time since April by an FDA warning letter that has chided the company for repeated problems centered on the presence of toxic bacteria in finished products.
Medline earns FDA warning letter ire for repeated toxic bacteria problems
Medline earns FDA warning letter ire for repeated toxic bacteria problems is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: FierceBiotech